| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||
- | - | - | 0 | - | - | - | 0 | 0 |
OPERATING EXPENSES | ||||||||
General and administrative | ||||||||
1,299 | 1,124 | 1,916 | 1,676 | 1,298 | -428 | 885 | 5,886 | 2,742 |
Research and development | ||||||||
792 | 1,207 | 1,167 | 293 | 612 | 2,308 | 654 | 287 | 104 |
Waiver of common stock issuable | ||||||||
- | - | - | 1,542 | - | - | - | - | - |
Total operating expenses | ||||||||
2,092 | 2,332 | 3,084 | 428 | 1,911 | 1,879 | 1,539 | 6,173 | 2,846 |
LOSS FROM OPERATIONS | ||||||||
-2,092 | -2,332 | -3,084 | -428 | -1,911 | -1,879 | -1,539 | -6,173 | -2,846 |
OTHER INCOME | ||||||||
Interest income | ||||||||
21 | 14 | 17 | 36 | 10 | - | - | - | - |
Total other income | ||||||||
21 | 14 | 17 | 36 | 10 | - | - | - | - |
NET LOSS | ||||||||
-2,070 | -2,318 | -3,066 | -392 | -1,901 | -1,879 | -1,539 | -6,173 | -2,846 |
Net loss per common share - basic and diluted | ||||||||
-0.19 | -0.23 | -0.28 | -0.04 | -0.20 | -0.21 | -0.18 | -0.71 | -0.33 |
Weighted average number of common shares outstanding - basic and diluted | ||||||||
10,747 | 10,788 | 10,762 | 10,150 | 9,388 | 8,721 | 8,719 | 8,719 | 8,546 |
COMPREHENSIVE LOSS | ||||||||
NET LOSS | ||||||||
-2,070 | -2,318 | -3,066 | -392 | -1,901 | -1,879 | -1,539 | -6,173 | -2,846 |
Other comprehensive loss - loss on foreign currency translation | ||||||||
-20 | - | -35 | - | -0 | - | -7 | - | - |
Other comprehensive loss - loss on foreign currency translation | ||||||||
- | - | - | -25 | - | - | - | -30 | 14 |
Total comprehensive loss | ||||||||
-2,091 | -2,271 | -3,102 | -417 | -1,901 | -1,882 | -1,547 | -6,203 | -2,831 |